Literature DB >> 23924475

Novel role of microRNAs in prostate cancer.

Jun-jie Yu1, Shu-jie Xia.   

Abstract

OBJECTIVE: To discuss the novel biomarkers of microRNAs in prostate cancer. DATA SOURCES: The literatures about microRNAs and prostate cancer cited in this review were obtained mainly from Pubmed published in English from 2004 to 2012. STUDY SELECTION: Original articles regarding the novel role of microRNAs in prostate cancer were selected.
RESULTS: MicroRNAs play an important role in prostate cancer such as cell differentiation, proliferation, apoptosis, and invasion. Especially microRNAs correlate with prostate cancer cell epithelial-mesenchymal transition (EMT), cancer stem cells (CSCs), drug sensitivity, cancer microenvironment, energy metabolism, androgen independence transformation, and diagnosis prediction.
CONCLUSIONS: MicroRNAs are involved in various aspects of prostate cancer biology. The role of microRNA in the initiation and development of prostate cancer deserves further study.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23924475

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  5 in total

1.  MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT.

Authors:  Rong Fan; Jie Zhong; Sichang Zheng; Zhengting Wang; Ying Xu; Shuyi Li; Jie Zhou; Fei Yuan
Journal:  Tumour Biol       Date:  2013-12-29

Review 2.  Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments.

Authors:  C R Balistreri; G Candore; D Lio; G Carruba
Journal:  Cancer Gene Ther       Date:  2014-01-10       Impact factor: 5.987

3.  MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma.

Authors:  Yong-Qing Tong; Bei Liu; Hong-Yun Zheng; Jian Gu; Hang Liu; Feng Li; Bi-Hua Tan; Melanie Hartman; Chunhua Song; Yan Li
Journal:  Oncotarget       Date:  2015-09-22

4.  CDX2/mir-145-5p/SENP1 Pathways Affect LNCaP Cells Invasion and Migration.

Authors:  Jin-Hua He; Ze-Ping Han; Mao-Xian Zou; Meng-Ling He; Yu-Guang Li; Lei Zheng
Journal:  Front Oncol       Date:  2019-06-12       Impact factor: 6.244

5.  miR-615 Inhibits Prostate Cancer Cell Proliferation and Invasion by Directly Targeting Cyclin D2.

Authors:  Fengyu Huang; Hongjun Zhao; Zhaojin Du; Hong Jiang
Journal:  Oncol Res       Date:  2018-02-22       Impact factor: 5.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.